Related Experiment Videos
[Hemodialysis and complement (author's transl)]
Insights
Patients undergoing hemodialysis show decreased C3 and CH50 complement levels, suggesting consumption via the alternative pathway. Further research is needed to confirm this hypothesis and explore potential triggers.
Area of Science:
- Immunology
- Nephrology
Context:
- Serum complement activity alterations observed in patients undergoing periodic hemodialysis.
- Preliminary study conducted on 44 patients undergoing hemodialysis.
Purpose:
- To repeatedly determine the activity of C3, C4, and CH50 in hemodialysis patients.
- To investigate the cause of observed complement system alterations.
Summary:
- A consistent drop in C3 and CH50 complement factors was observed, while C4 levels remained normal.
- Findings suggest complement consumption is more likely than decreased synthesis, potentially via the alternative pathway.
- Liver disease was ruled out as a cause due to inconsistent presence and lack of correlation with C3 levels.
Impact:
- Highlights the need for further investigation into complement system activation during hemodialysis.
- Suggests potential mechanisms like dialysis-related processes, cleaning chemicals, or medications may trigger complement consumption.
- Emphasizes the necessity of long-term studies to understand the repercussions of these complement alterations.
Abstract:
After observing alterations in the activity of the serum complement in patients undergoing periodic hemodialysis, the authors performed a preliminary study to determine repeatedly the activity of C3, C4, and CH50 in 44 patients. They discovered a consistent drop in C3 and CH50 while C4 remained normal. An attempt to explain these findings with information from the literature offered no more than a hypothesis for further study. While the possibility of a decline in the synthesis of the complement factors cannot be disregarded, the authors believe it is much more probable that they are consumed at a rate higher than normal. Since the C4 factor does not appear to be involved, activation is probably along the alternative pathway. Defective synthesis cannot be attributed to liver disease because the latter is not always present and because there is no relationship between C3 levels and levels of albumin or the presence of hepatopathy. The literature was reviewed for data that might support the idea that the complements in these patients are activated continuously by some process in connection with dialysis, by chemical products employed for to clean the machines, by commonly administered drugs, etc. Because so few data could be found on the subject, the authors consider that is necessary to study these mechanisms and their repercussions over a longer period of time.